Why is the Supreme Court skeptical of Trump's tariffs?
How will FAA flight cuts impact U.S. airports?
What caused Diageo’s share price to hit a decade low?
How did Google’s AI investments affect its growth plans?
Why are U.S. layoffs rising amidst strong corporate profits?
What does Mamdani’s NYC mayor win mean for business?
How is AI transforming job hiring and layoffs?
Uniqure Plummets 59% On A 'Confusing' And 'Unexpected' Twist For Its Gene Therapy
investors.com/news/technology/uniqure-stock-huntingtons-gene-therapy-fda-feedback
stock crashed Monday on "confusing" and "unexpected" feedback from the Food and Drug Administration for its Huntington's disease gene therapy.
The company "believes that the FDA currently no longer agrees that the data from the Phase I/II studies of AMT-130 in comparison to an external…
This story appeared on investors.com, 2025-11-03 16:18:22.863000.